📰 Clinical Program Highlights News

Clinical Program Highlights News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Clinical Program Highlights. Real-time updates on events, politics, business and more.

Vigil Neuroscience Provides 2023 Year-in-Review and Highlights Upcoming 2024 Milestones

January 3, 2024

- On track to report interim Phase 1 data for VG-3927 in healthy volunteers in mid-2024 and Phase 2 results from IGNITE clinical trial evaluating iluzanebart in ALSP in Q3 2024 - - Extends projected...

Megan Mcgrath Ivana Magov Leah Gibson Key Clinical Program European Commission Vigil Neuroscience Inc

Source: marketscreener.com

Bellerophon Provides Clinical Program Update and Reports First Quarter 2023 Financial Results

May 15, 2023

15.05.2023 - Last Patient Completed Blinded Treatment in REBUILD Phase 3 Trial for INOpulse; Pivotal Top-line Data Expected in Mid-2023 WARREN, N.J., May 15, 2023 (GLOBE NEWSWIRE) - Bellerophon Therapeutics, Inc. (Nasdaq: BLPH) (“Bellerophon” or the ...

New Jersey United States Baylor Biosciences Brian Ritchie Baylor Biosciences Inc Exchange Commission

Source: wallstreet-online.de

Portage Biotech Announces Results for Fiscal Quarter Ended

November 29, 2022

--Updated Data on Phase 1/2 Trial Evaluating PORT-2 Presented at the Society for Immunotherapy of Cancer’s (SITC) Annual Meeting-- --Clinical...

United States Development Agreement Society For Immunotherapy Of Cancer American Society Of Clinical Oncology Development Committee Merck Co

Source: globenewswire.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science

Navigation

Clinical Program Highlights News Today

Vigil Neuroscience Provides 2023 Year-in-Review and Highlights Upcoming 2024 Milestones

Bellerophon Provides Clinical Program Update and Reports First Quarter 2023 Financial Results

Portage Biotech Announces Results for Fiscal Quarter Ended

Explore More Categories